R Ramasubbu

Summary

Affiliation: University of Ottawa
Country: Canada

Publications

  1. pmc Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression
    R Ramasubbu
    Department of Psychiatry, University of Ottawa, Ont
    J Psychiatry Neurosci 24:45-50. 1999
  2. ncbi request reprint Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study
    R Ramasubbu
    Department of Psychiatry, University of Ottawa, Royal Ottawa Hospital, Ont, Canada
    Psychoneuroendocrinology 25:139-50. 2000
  3. ncbi request reprint Relationship between depression and cerebrovascular disease: conceptual issues
    R Ramasubbu
    Department of Psychiatry, University of Ottawa, Royal Ottawa Hospital, 1145 Carling Avenue, Ottawa, Ontario, Canada
    J Affect Disord 57:1-11. 2000
  4. ncbi request reprint Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs
    R Ramasubbu
    Department of Psychiatry, University of Ottawa, Royal Ottawa Hospital, Ontario, Canada
    Pharmacopsychiatry 33:236-8. 2000
  5. ncbi request reprint Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases
    R Ramasubbu
    Department of Psychiatry, University of Calgary, Foothills Hospital, Canada
    Med Hypotheses 59:537-51. 2002
  6. ncbi request reprint Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders
    R Ramasubbu
    Department of Psychiatry, University of Ottawa, Royal Ottawa Hospital, Ontario, Canada
    Acta Psychiatr Scand 104:236-8; discusiion 238-9. 2001

Detail Information

Publications6

  1. pmc Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression
    R Ramasubbu
    Department of Psychiatry, University of Ottawa, Ont
    J Psychiatry Neurosci 24:45-50. 1999
    ..To determine the efficacy of substituting moclobemide, a reversible monoamine oxidase-A inhibitor, for fluoxetine to reverse fluoxetine-induced sexual dysfunction in patients with depression...
  2. ncbi request reprint Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study
    R Ramasubbu
    Department of Psychiatry, University of Ottawa, Royal Ottawa Hospital, Ont, Canada
    Psychoneuroendocrinology 25:139-50. 2000
    ..An age-related decline in serotonergic function must be considered in determining the dose requirement for maximal hormonal responses to D-FEN challenge tests in the elderly...
  3. ncbi request reprint Relationship between depression and cerebrovascular disease: conceptual issues
    R Ramasubbu
    Department of Psychiatry, University of Ottawa, Royal Ottawa Hospital, 1145 Carling Avenue, Ottawa, Ontario, Canada
    J Affect Disord 57:1-11. 2000
    ..The association between cerebrovascular disease (CVD) and depression has been well described, but our understanding of various aspects of the relationship between these two disorders remains limited...
  4. ncbi request reprint Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs
    R Ramasubbu
    Department of Psychiatry, University of Ottawa, Royal Ottawa Hospital, Ontario, Canada
    Pharmacopsychiatry 33:236-8. 2000
    ....
  5. ncbi request reprint Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases
    R Ramasubbu
    Department of Psychiatry, University of Calgary, Foothills Hospital, Canada
    Med Hypotheses 59:537-51. 2002
    ..More studies are needed to examine the importance of improving insulin sensitivity in the treatment of chronic-resistant depression and prevention of depression-related vascular morbidity and mortality...
  6. ncbi request reprint Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders
    R Ramasubbu
    Department of Psychiatry, University of Ottawa, Royal Ottawa Hospital, Ontario, Canada
    Acta Psychiatr Scand 104:236-8; discusiion 238-9. 2001
    ..No hypomanic switch was observed during 18-24 months follow-up. CONCLUSION: In the absence of risk factors for manic switch, SSRI-induced hypomania may be dose-dependent medication effects...